Viewing Study NCT04729959


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2026-02-05 @ 11:47 PM
Study NCT ID: NCT04729959
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2021-01-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diffuse Astrocytoma, IDH-Wildtype View
None Recurrent Glioblastoma View
Keywords: